Delivery Order SPE2DB24D2205-SPE2DB25FEFWJ
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 28, 2025, for the supply of Dexcom G7 sensors, with a ceiling value of $1,787.20. This competitively awarded, firm fixed-price delivery order is scheduled for completion by August 29, 2025, and will be performed at the contractor's corporate office in Conshohocken, Pennsylvania. The contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $2,130.18 for Dexcom G7 sensors on August 7, 2025, with an ultimate completion date of August 8, 2025. This firm fixed price contract represents a child award under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The award was competitively awarded with no set-aside designation and will...
- The Defense Logistics Agency awarded a delivery order valued at $3,415.48 to AmerisourceBergen Drug Corp for Dexcom G7 sensors on August 19, 2025, with an ultimate completion date of August 20, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. The contract will be performed at the awardee's corporate headquarters in Conshohocken, Pennsylvania....
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Dexcom G7 continuous glucose monitoring sensors, valued at $3,093.60. This is a firm fixed-price delivery order with an ultimate completion date of August 5, 2025, and represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract with the Defense Logistics Agency Troop Support Medical (SPE2DX), valued at $999.999...
- The Defense Logistics Agency awarded a delivery order valued at $1,135.84 to AmerisourceBergen Drug Corp for Dexcom G7 sensors on August 25, 2025, with completion scheduled for August 26, 2025. The contract utilizes firm fixed pricing and was awarded without a set-aside designation through open competition. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical federal medical procurement vendor specializing in pharmaceutical products...
- The Defense Logistics Agency awarded a $2,167.32 firm fixed price delivery order to AmerisourceBergen Drug Corp for Dexcom G7 sensors on May 14, 2025, with completion targeted for May 15, 2025. This non-competitive delivery order represents a child contract under AmerisourceBergen's broader pharmaceutical and medical supply relationship with DLA. The sensors will be delivered to the contractor's facility in Conshohocken, Pennsylvania, supporting federal healthcare procurement needs. This award...
- The Defense Logistics Agency awarded a $12,809.52 firm fixed price delivery order to AmerisourceBergen Drug Corp for Dexcom G7 sensors, with an ultimate completion date of September 12, 2025. This non-set-aside competitive award was issued on September 11, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a $1,023.62 firm fixed-price delivery order for Dexcom G7 sensors, with an ultimate completion date of September 5, 2025. This competitively awarded contract, issued on September 4, 2025, represents a child order under AmerisourceBergen's larger indefinite delivery contract (IDC) with DLA Troop Support Medical. The delivery order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $1,031.20 to AmerisourceBergen Drug Corp for Dexcom G7 sensors on August 15, 2025, with an ultimate completion date of August 18, 2025. This is a firm fixed price, non-set-aside contract with performance at the contractor's Conshohocken, Pennsylvania location. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which...
- The Defense Logistics Agency awarded a delivery order valued at $4,981.76 to AmerisourceBergen Drug Corp for Dexcom G7 sensors on September 16, 2025, with an ultimate completion date of September 17, 2025. This firm fixed-price, competitively awarded contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999.999 billion through December 2026. The order will be fulfilled from the vendor's...
- SPE2DB24D2205Indefinite Delivery Contract
- SPE2DB24D2205-SPE2DB25FEFWJDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Dexcom G7 sensors on August 5, 2025, with a ceiling value of $1,260.46. This firm fixed-price delivery order, which is not set aside for small business or other categories, is scheduled for completion by August 6, 2025, and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The contract represents a child award under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vendor agreement valued through December 2026 that enables the contractor to supply pharmaceuticals and medical supplies to support military healthcare programs globally. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that serves as a critical vendor for federal medical procurement, particularly for military and veteran healthcare systems. The company has established a strong track record fulfilling competitively awarded delivery orders through the DLA Medical Supply Chain, providing a comprehensive portfolio of pharmaceuticals, medical devices, and specialized healthcare commodities across multiple therapeutic domains. This award of continuous glucose monitoring sensors reflects the contractor's ongoing role in supplying specialized medical devices to support Defense Health Agency and other government healthcare system requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 8/5/25 |